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Abstract
Genomic rearrangements describe gross DNA changes of the size ranging from a couple of
hundred base pairs, the size of an average exon, to megabases (Mb). When greater than 3 to 5 Mb,
such changes are usually visible microscopically by chromosome studies. Human diseases that
result from genomic rearrangements have been called genomic disorders. Three major mechanisms
have been proposed for genomic rearrangements in the human genome. Non-allelic homologous
recombination (NAHR) is mostly mediated by low-copy repeats (LCRs) with recombination
hotspots, gene conversion and apparent minimal efficient processing segments. NAHR accounts for
most of the recurrent rearrangements: those that share a common size, show clustering of
breakpoints, and recur in multiple individuals. Non-recurrent rearrangements are of different sizes
in each patient, but may share a smallest region of overlap whose change in copy number may result
in shared clinical features among different patients. LCRs do not mediate, but may stimulate non-
recurrent events. Some rare NAHRs can also be mediated by highly homologous repetitive
sequences (for example, Alu, LINE); these NAHRs account for some of the non-recurrent
rearrangements. Other non-recurrent rearrangements can be explained by non-homologous end-
joining (NHEJ) and the Fork Stalling and Template Switching (FoSTeS) models. These mechanisms
occur both in germ cells, where the rearrangements can be associated with genomic disorders, and
in somatic cells in which such genomic rearrangements can cause disorders such as cancer. NAHR,
NHEJ and FoSTeS probably account for the majority of genomic rearrangements in our genome
and the frequency distribution of the three at a given locus may partially reflect the genomic
architecture in proximity to that locus. We provide a review of the current understanding of these
three models.
Introduction
Genomic rearrangements describe mutational changes in
the genome such as duplication, deletion, insertion,
inversion, and translocation that are different from the
traditional Watson-Crick base pair alterations [1].
Genomic rearrangements can represent polymorphisms
that are neutral in function, or they can also convey phe-
notypes via diverse mechanisms, including changing the
copy number (that is, copy number variation or CNV) of
dosage-sensitive genes, disrupting genes, creating fusion
genes or other mechanisms (reviewed in [1]). The patho-
logical conditions caused by genomic rearrangements are
collectively defined as genomic disorders [1-3].
Published: 3 November 2008
PathoGenetics 2008, 1:4 doi:10.1186/1755-8417-1-4
Received: 9 June 2008
Accepted: 3 November 2008
This article is available from: http://www.pathogenetics.com/content/1/1/4
© 2008 Gu et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.PathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
Page 2 of 17
(page number not for citation purposes)
Typically, the term 'genomic rearrangements' is only used
to describe gross DNA changes ranging from thousands to
sometimes millions of base pairs that can cover clusters of
different genes [1]. Genomic rearrangements of this size
have been considered to be clearly distinct from the small-
scale gene mutations (for example, point mutations,
indels) regarding not only the size of the rearranged DNA
but also the underlying mechanisms for both the forma-
tion of the rearrangements and the conveying of pheno-
types (that is, mechanisms upstream and downstream of
the rearrangements). Monogenic point mutations usually
reflect errors of DNA replication and/or repair [1,2],
whereas the gross genomic rearrangements are often
caused by other mechanisms mediated or stimulated by
genomic structural features (that is, genomic architecture)
[1]. Disease-causing genomic rearrangements can be
recurrent, with a common size and fixed breakpoints (that
is, breakpoints cluster); or non-recurrent with different
sizes and distinct breakpoints for each event. The non-
recurrent rearrangements share a common genomic
region-of-overlap, the smallest region of overlap (SRO),
that encompasses the locus associated with the conveyed
genomic disorder (Figure 1).
Three major mechanisms have been proposed for
genomic rearrangements in the human genome: non-
allelic homologous recombination (NAHR), non-homol-
ogous end-joining (NHEJ) and the Fork Stalling and Tem-
plate Switching (FoSTeS) models.
Recurrent genomic rearrangements are caused 
by NAHR
1. NAHR occurs preferentially at the so-called 'hotspots' 
inside low-copy repeats
A large number of DNA rearrangements of the same
genomic interval have been observed in different individ-
uals, that is they have a recurrent nature [1]. Most recur-
rent genomic rearrangements are caused by NAHR
between two low-copy repeats (LCRs, also called segmen-
tal duplications, SD) [4,5]. LCRs are region-specific DNA
blocks usually of 10 to 300 kilobase (kb) in size and of >
95% to 97% similarity to each other [5,6]. Bailey and
Eichler recently reviewed the distribution and evolution
of mammalian LCRs (referred to as SD therein) [6].
Due to their high degree of sequence identity, non-allelic
copies of LCRs, instead of the copies at the usual allelic
positions, can sometimes be aligned in meiosis or mitosis.
This so-called 'misalignment' and the subsequent crosso-
ver between them can result in genomic rearrangements
in progeny cells. The non-allelic copies thus act as the
mediators (that is, substrates) of the homologous recom-
bination and they are responsible for the observed break-
point clustering. When the two LCRs are located on the
same chromosome and in direct orientation, NAHR
between them causes duplication and/or deletion. When
they are on the same chromosome but in opposite orien-
tation, NAHR results in inversion of the fragment flanked
by them [2] (Figure 2a). NAHR between repeats on differ-
ent chromosomes can lead to chromosomal translocation
[2].
Evidence has shown that the strand exchanges during
NAHR are not distributed evenly along the LCRs, but clus-
ter in narrow 'hotspots' [7-10]. DNA structures capable of
inducing double-strand breaks (DSB) (such as palin-
dromes, non-B conformation DNA, minisatellites and
DNA transposons) have often been found near the NAHR
hotspots, indicating a potential link between NAHR and
DSB [11,12]. At the same time, extensive linkage disequi-
librium studies as well as detailed mapping of single loci
clearly revealed that allelic homologous recombination
(AHR) also has preferred hotspots [13-15].
Using sequencing-based approaches, De Raedt et al. [16]
and Lindsay et al. [17] examined the fine structure of
crossovers at the Neurofibromatosis type 1 (NF1;
MIM162200) locus and Charcot-Marie-Tooth disease
type 1A (CMT1A; MIM118220)/Hereditary Neuropathy
with Liability to Pressure Palsies (HNPP; MIM162500)
locus which often undergo NAHR. De Raedt et al. showed
that NAHR hotspots can have strikingly similar positions
in the LCR as the AHR hotspots in paralogous sequences
[16]. Lindsay et al. found that in the same sequence frag-
ment, NAHR hotspots can be located just adjacent to AHR
hotspots and share similar properties of the distribution
of strand exchanges [17]. These data provided evidence
that the NAHR hotspots could be functionally closely
related to AHR hotspots. Some of the NAHR and AHR
hotspots still fall into the same regions in the current
human genome; some of them may have overlapped in
our ancestral genomes [16].
2. NAHR occurs in both meiotic and mitotic cells
NAHR in germ line cells leads to constitutional genomic
rearrangements that can be manifested as genomic disor-
ders [1,18]. Genomic disorders can be either inherited or
sporadic, depending on whether the rearrangement was
transmitted through the germ line or occurred de novo
[19]. Prominent examples of inherited genomic disorders
caused by NAHR include CMT1A and HNPP, caused by
the recurrent duplication/deletion of a 1.4 Megabase
(Mb) DNA fragment on chromosome 17p12; and spo-
radic genomic disorders include Potocki-Lupski syn-
drome (PTLS; MIM610883)/Smith-Magenis syndrome
(SMS; MIM182290) caused by the reciprocal duplication/
deletion on 17p11.2. The identification and detailed
study of these rearrangements in patients has contributed
significantly to our current knowledge on mechanisms ofPathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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genomic rearrangements (the reports delineating the first
recurrent disease-associated duplication rearrangement
include [20,21], recently reviewed in [1,22]).
NAHR can also occur in mitosis, resulting in mosaic pop-
ulations of somatic cells carrying genomic rearrange-
ments. It is well appreciated that many cancers are related
to somatic genomic rearrangements, some due to somatic
NAHR [23,24]. Also, in blood cells of healthy persons
elaborate PCR assays have been able to detect mosaic
duplication, deletion [25,26] and inversion mediated by
NAHR [27]. CNVs have been shown between monozy-
gotic twins, highlighting the potential occurrence of
genomic rearrangements in somatic cells [28]. Somatic
NAHR can cause genomic disorders with mosaic manifes-
tations, one example being the somatic NF1 deletions
causing segmental neurofibromatosis [29]. Interestingly,
Dempsey et al. reported a patient with mosaicism for both
Experimental observations of recurrent and non-recurrent genomic rearrangements associated with genomic disorders Figure 1
Experimental observations of recurrent and non-recurrent genomic rearrangements associated with genomic 
disorders. The long thin line signifies the genomic region undergoing genomic rearrangements. The black rectangle depicts a 
gene which is located in the rearranged region and can be affected by the rearrangements. The thick blue (in a) and red (in b 
and c) bars represent the rearrangements (duplications, deletions or inversions) with their breakpoints a. recurrent rearrange-
ments with a common size and clustered breakpoints. Most of the recurrent rearrangements result from non-allelic homolo-
gous recombination (NAHR). The two hatched rectangles flanking the gene depict the low-copy repeats (LCRs) functioning as 
substrates for NAHR. The rearrangement breakpoints are clustered inside the LCRs. b. Non-recurrent rearrangements. The 
breakpoints of the non-recurrent rearrangements are scattered in the genomic region. Note, that all of the rearrangements 
share a common genomic region of overlap, the smallest region of overlap, that encompasses a gene necessary for the con-
veyed phenotypic trait, which enables these rearrangements to be ascertained. c. Non-recurrent rearrangements with group-
ing of one breakpoint. Some of the non-recurrent rearrangements have one of their breakpoints localized in one small genomic 
region. This grouping of breakpoints is distinct from breakpoint clustering, but like clustering, it may reflect underlying genomic 
architecture (for example, palindrome or cruciform) important to the rearrangement mechanism, depicted as the dotted rec-
tangle in Figure 1c.PathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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deletion del(22)(q11.2q11.2) and the reciprocal duplica-
tion dup(22)(q11.2q11.2), which were probably caused
by a mitotic NAHR event early in embryogenesis [30].
The same pairs of LCRs can mediate both mitotic and mei-
otic NAHR events. The LCRs called REPA and REPB map-
ping in 17p11.2 are important mediators of somatic
NAHRs leading to the formation of the dicentric isochro-
mosome i(17q) in human neoplasia [31,32]; they also
Genomic re-arrangement (Adapted from [2] and [5]) Figure 2
Genomic rearrangements (Adapted from [2] and [5]). a1 and a2 Genomic rearrangements resulting from recombina-
tion between low-copy repeats (LCRs). LCRs are depicted as black arrows with the orientation indicated by the direction of 
the arrowhead. Capital letters above the thin horizontal lines refer to the flanking unique sequences (for example, A). Homo-
logues on the other strand (can be another chromatid or the homologous chromosome) are also shown (for example, a). Thin 
diagonal lines refer to a recombination event with the results shown by numbers 1, 2 and 3. a1 Recombination between direct 
repeats results in deletion and/or duplication. a2 Recombination between inverted repeats results in an inversion. b. Schematic 
representation of reciprocal duplications and deletions mediated by interchromosomal (left), interchromatid (middle) and 
intrachromatid (right) non-allelic homologous recombination (NAHR) using LCR pairs in direct orientation. Chromosomes are 
shown in black, with the centromere depicted by hashed lines. Yellow arrows depict LCRs. Letters adjacent to the chromatids 
refer to the flanking unique sequence (for example, A, a). Interchromosomal and interchromatid NAHR between LCRs in 
direct orientation result in reciprocal duplication and deletion, whereas intrachromatid NAHR only creates deletion. Signa-
tures of homologous recombination include the sequence identity of the substrates (LCRs) used for NAHR, recombination 
hotspots within the LCRs, and evidence for gene conversion at the crossovers within the LCRs.PathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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convey frequent meiotic NAHRs and cause this genomic
locus to be highly variable in different populations [33].
Mitotic NAHR may not share the same hotspots with the
meiotic NAHR mediated by the same pair of LCRs, as sug-
gested by the observation of Turner et al. in their sperm-
typing assay, where the primer pairs amplifying across the
meiotic recombination hotspots in sperm DNA could not
amplify any recombinant products from the DNA of
blood cells [18]. The frequency of meiotic and mitotic
NAHR on the same LCRs can be different as well [25]. Fur-
thermore, the frequency and LCR usage of mitotic NAHRs
could, theoretically, even vary among different somatic
tissues although, to our knowledge, no data are currently
available on this topic. Future studies using precise tech-
niques to examine more loci should reveal further details
on the similarities and differences between meiotic and
mitotic NAHR.
3. Minimal efficient processing segments are required for 
efficient NAHR
For NAHR to take place, there must be segments of a min-
imal length sharing extremely high similarity or identity
between the LCRs, named minimal efficient processing
segments (MEPS). The importance of MEPS for intra- and
interchromosomal mitotic recombination was demon-
strated by Waldman and Liskay using mouse cell culture
[34] and by Rubnitz and Subramani using monkey cell
culture [35]. The placement of only two single-nucleotide
mismatches, reducing the longest uninterrupted homol-
ogy between two repeats from 232 to 134 base pairs (bp),
resulted in a 20-fold reduction in intrachromosomal
recombination [34]. Also, the frequency of interchromo-
somal recombination drops sharply when the homology
was reduced from 214 to 163 bp [35].
The MEPS in human meiosis appear to be in the range of
300 to 500 bp in length, as empirically estimated from the
analysis of the genomic rearrangements in CMT1A/HNPP
patients [36]. The MEPS of mitotic NAHR may be differ-
ent from meiotic NAHR. Steinmann et al. [29] identified
nine somatic NF1 deletions conveyed by homology
stretches shorter than 114 base pairs. Not all meiosis or
mitosis events have the same demand of MEPS. With their
single sperm/cell assay, Lam and Jeffreys [25] identified
both meiotic and mitotic NAHR events between human
alpha-globin genes mediated by matching fragments
smaller than 50 bp [25]. The modest demand on MEPS in
this case could be related to the proximity between the
two NAHR substrate repeats. The distance between two
LCRs is known to be one of the genomic architectural fea-
tures that influence the efficiency of NAHR [2,5,37], and
it has been observed that larger-sized genomic rearrange-
ments, utilizing LCRs located further apart, often correlate
with larger LCRs [2,5]. The repeats in the alpha-globin
locus are only 5 kb away from each other, whereas the two
LCRs of CMT1A/HNPP are separated by 1.4 Mb. Never-
theless, most of the rearrangements causing genomic dis-
orders actually take place between LCRs which are 10 to
400 kb in length and have > 96% sequence identity [2,37].
The most frequent microdeletion syndrome, DiGeorge/
Velocardiofacial (DG/VCFS; MIM188400, 192340) (fre-
quency 1/4,000–1/8,000), is mediated by LCRs on chro-
mosome 22q11.2, of 240 kb in length and sharing 99.7%
sequence identity [38,39].
4. Reciprocal deletions and duplications do not occur at 
the same frequencies
The relative frequency of the reciprocal deletions and
duplications from the NAHR events mediated by the same
pair of LCRs is of both biological and clinical importance.
In meiosis, NAHR can take place between paralogues on
the same chromatid (intrachromatid), on sister chroma-
tids (intrachromosomal or interchromatid) or on the
homologous chromosomes (interchromosomal) [5,18].
Between two directly oriented LCRs, interchromatid and
interchromosomal rearrangements result in reciprocal
duplication and deletion, whereas intrachromatid rear-
rangements can only lead to deletion (Figure 2b). Thus, at
least theoretically, the frequency of deletions should be
always higher than duplications. The difference between
the frequency of deletions and duplications reflects the
frequency of intrachromatid NAHR.
The prevalence of several reciprocal duplication/deletion
syndromes such as CMT1A/HNPP, PTLS/SMS,
dup22(q11.2q11.2)/DG/VCFS has been used to estimate
the relative frequency of duplications and deletions medi-
ated by the same pairs of LCRs. The pitfall of these calcu-
lations is that one or even both events might be
embryonically lethal or phenotypically mild so that the
carriers will not be clinically ascertained. Furthermore,
selection would occur in both germ cells and the organ-
ism, and may act differently on duplication versus dele-
tion syndromes. To overcome these challenges, two
groups took an experimental approach that used a single-
sperm PCR assay to measure the duplication and deletion
events directly. Turner et al. analyzed four NAHR loci
related to well-studied genomic disorders (Williams-
Beuren Syndrome deletion (WBS; MIM194050) and
7q11.23 duplication (MIM609757); the AZFa deletion
(azoospermia (MIM415000) associated) and its recipro-
cal duplication; the HNPP deletion and CMT1A duplica-
tion; and the SMS deletion and PTLS duplication) in the
sperm populations of five persons. Strikingly, they found
that all five persons consistently displayed an approxi-
mately 2:1 ratio of deletion versus duplication in all three
autosomal loci. For the AZFa locus on the Y-chromosome,
the observed deletion versus duplication ratio 4:1 was
even higher [18]. Thus, at least in meiosis, reciprocalPathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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duplications and deletions do not occur at equal fre-
quency [18].
It is not clear how general this 'two deletions versus one
duplication' rule is. Lam and Jeffreys [25,26] also per-
formed single-sperm assays on the alpha-globin locus in
two persons. One person showed the same deletion and
duplication frequency, while the other person had a
higher rate of duplications than deletions at this locus.
This discrepancy between the two studies could be due to
experimental design, as Turner et al. specifically measured
the NAHR events across the so-called 'hotspots' in the LCR
whereas Lam and Jeffreys observed the entire globin locus
and could thus also record NAHR events outside the
hotspots and other non-NAHR rearrangements. However,
it could also reflect true differences among different
NAHR loci, probably predisposed by the local genomic
architecture (LCR length, distance of LCRs and so on).
Pedigree analysis of the haplotypes flanking the LCRs has
often been used to differentiate between intra- and inter-
chromosomal rearrangements [40-45]. These studies have
revealed different findings for different syndromes. How-
ever, the haplotype assay has the limitation of being una-
ble to differentiate between intrachromatid and
interchromatid events, so the comparison can only be
made between intrachromosomal (intra- plus interchro-
matid) and interchromosomal NAHR.
The single-sperm assay, however, allows the assessment of
the intrachromatid events by observing the difference
between deletion and duplication frequencies. Turner et
al. [18] concluded that intrachromatid NAHR dominates
at all hotspots they examined and the interchromatid
NAHRs are very rare, with a frequency 50-fold lower than
interchromosomal NAHRs. That the deletion versus
duplication ratio at AZFa locus on Y chromosome is even
higher than at the autosomal loci is likely because of the
lack of interchromosomal NAHR.
The conclusion of Turner et al. agrees with the study of the
WBS locus by Bayes et al. [44]. However, it awaits further
confirmation from data at other loci before it can be
accepted as a general rule. One should also bear in mind
that this finding is only relevant for the NAHR events at
the hotspots and does not describe any other types of rear-
rangements caused by different mechanisms.
5. NAHR can be different between males and females
There seem to be differences in NAHR frequency between
male and female gametogenesis, as reflected by the differ-
ent percentage of the two parental origins which were
observed for several genomic disorders. The overwhelm-
ing majority of CMT1A duplications (nine in nine cases as
reported in [46] and 26 in 28 cases in [47]) as well as 85%
of spinal muscular atrophy (SMA; MIM253300) deletions
[48] originate in spermatogenesis; whereas 80% of NF1
deletions are of maternal origin [8,49]. These apparent
differences in maternally and paternally originated rear-
rangements might be due to intrinsic differences in NAHR
between male and female germ lines, or might also reflect
different selection bias against the rearranged allele
between male and female germ lines, or a combination of
both. Epigenetic modifications in male and female game-
togenesis and gametes might contribute to both processes.
The observed differences between male and female rear-
rangements do not seem to affect all NAHR loci to the
same extent: for SMS/PTLS, no significant parental differ-
ences have been observed [50,51].
Whereas meiotic NAHRs causing genomic rearrangements
either originate in or are inherited through the germ line
of the previous generation, mitotic NAHRs occur in the
somatic cells of the same individual who bears the rear-
rangements. It is intriguing that mitotic NAHR could also
have a bias in females and males. Steinmann et al. [29]
observed that 12 of their 13 segmental NF patients with
deletions caused by somatic NAHR are females. The rea-
son for this bias is not immediately obvious; it is not
known if this bias is specific for the genomic locus or
somatic tissues involved in the pathogenesis of NF, or
whether it may reflect more general differences between
male and female mitotic NAHR. Little data are available at
the present time.
6. Using the NAHR mechanism to predict genomic 
disorders
The recognition of NAHR originated from the study of
genomic disorders [2]. It is thus exciting that our now
greater understanding of NAHR mechanisms, combined
with bioinformatic analyses of the human genome, allows
the prediction of regions prone to genomic instability,
thus uncovering novel genomic disorders.
First, where recurrent deletions mediated by LCRs have
been observed, we can confidently predict the occurrence
of reciprocal duplication at the same sites, and vice versa.
In recent years, with the application of mechanistic
insight, we have witnessed the defining of the Potocki-
Lupski syndrome as the predicted reciprocal rearrange-
ment of SMS, dup(22)(q11.2) as the reciprocal rearrange-
ment of DG/VCFS, and dup(7)(q11.23) as the reciprocal
rearrangement for Williams-Beuren syndrome deletion
[50-55]. The above-mentioned sperm-typing data of
Turner et al. further confirmed the co-existence of the
reciprocal rearrangements by experiments, while pointing
out that the reciprocal syndromes can have unequal fre-
quencies compared with the prevalence of the deletion
syndromes.PathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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Our lab has reported a 5 Mb uncommon but recurrent
deletion in six SMS patients, which utilized alternative
LCRs as NAHR substrates [56]. Although the reciprocal
duplication of the common recurrent SMS deletion has
been found in a number of cases and led to the definition
of the PTLS syndrome, patients with the reciprocal dupli-
cation of the uncommon recurrent deletion have not yet
been identified. It is thus of great interest that Turner et al.
[18] did observe this duplication in their sperm assay, fur-
ther underscoring the reciprocal nature of NAHR and
affirming the anticipation that this duplication may also
be found in patients. It should be pointed out that until
now, we have only identified six uncommon recurrent
deletions in our cohort of SMS patients; if the frequency
of the reciprocal duplication is half that of the deletion,
patients with the uncommon duplication should be even
more rare.
Furthermore, the NAHR mechanisms based on LCRs have
also led to the finding of a number of new genomic disor-
ders. The majority of DG/VCFS patients have either a com-
mon 3 Mb or an atypical 1.5 Mb deletion on 22q11.2
mediated by LCR22-2 and LCR22-4, or LCR22-3a and
LCR22-4, respectively ([38,54,57] and the references
therein). The architecture of 22q11.2, however, also har-
bors additional LCR22s [38]. It was thus anticipated that
recombinations mediated by other LCRs might also occur
in this region. Indeed, using array comparative genomic
hybridization (aCGH) techniques, Ben-Shachar et al.
found six deletions mediated by LCR22-4, -5 and -6 [57].
These deletions are distal from the common DG/VCFS
deletions and the patients have phenotypes overlapping
with but distinct from DG/VCFS. These deletions were
defined as the 22q11.2 distal deletion syndrome
(MIM611867), a new genomic disorder https://deci
pher.sanger.ac.uk/perl/applica
tion?action=synes;syndrome_id=32[57]. The reciprocal
duplications of these distal deletions have also been
reported [54].
Also applying the principles of NAHR mediated by LCR,
Sharp et al. [37,58] predicted microdeletion/microdupli-
cation rearrangements in new chromosomal loci that were
previously not known to cause genomic syndromes. The
authors [58] created a map of potential 'rearrangement
hotspots' of the human genome, by localizing 130 sites of
paired LCRs (SD) that are  10 kb in length, show  95%
sequence identity and are separated by 50 kb to 10 Mb of
intervening sequence [37]. A specific bacterial artificial
chromosome (BAC) array was then designed including
BAC clones interrogating each of these 130 NAHR candi-
date sites [37]. After ruling out the basal level of copy
number polymorphisms in these sites by hybridizing a
control population of 316 individuals [37], the authors
analyzed the genomes of 290 idiopathic mental retarda-
tion patients and found deletions in four chromosomal
loci (17q21.31, 1q21.1, 15q13, and 15q24) that are likely
sites of recurrent rearrangements [58]. Three of the rear-
rangements were indeed identified as new microdeletion
syndromes, with further cases found in other populations
[58-60].
The microdeletion syndrome involving 17q21.31 was
also identified by two other groups with a traditional sys-
tematic whole-genome array assaying individuals with
idiopathic mental retardation [61-63]. In another study,
the candidate NAHR loci array of Sharp et al. was used to
assess 155 fetuses with congenital anomalies and identi-
fied a deletion involving 17q12 in a fetus with dysplastic
kidneys [64]. They extended their study to include addi-
tional cohorts of patients and found that the deletion is
also associated with congenital renal abnormalities and
diabetes. The deletions are all in the range of under 1 Mb
to 4 Mb in size, thus below the limit of the resolution of
traditional cytogenetic detection [59,61,63].
Interestingly, the reciprocal duplication of the microdele-
tion in 17q12 (mediated by the same LCRs) was identified
in two individuals with mental retardation and/or epi-
lepsy [64]. The reciprocal duplication of the 15q13 dele-
tion has also been identified in a healthy person [59] and
the reciprocal duplication of the 17q21.31 deletion was
reported in a patient with phenotypes including severe
psychomotor developmental delay and facial dysmor-
phism [65]. The duplications corresponding to the
remaining microdeletions will probably also be identified
soon, although it is not known yet what kind of pheno-
types will be related to them.
Some simple non-recurrent rearrangements can 
occur via NHEJ
NHEJ is one of the two major mechanisms used by
eukaryotic cells to repair DSB and has been described in
organisms from bacteria to mammals [66-68]. NHEJ is
routinely utilized by human cells to repair both 'physio-
logical' DSBs, such as in V(D)J recombinations, and 'path-
ological' DSBs, such as those caused by ionizing radiation
or reactive oxygen species. Inherited defects in NHEJ
account for about 15% of human severe combined immu-
nodeficiency (SCID) [69]. NHEJ is also currently consid-
ered to be the major mechanism rejoining translocated
chromosomes in cancer [70].
NHEJ proceeds in four steps (Figure 3a): detection of DSB;
molecular bridging of both broken DNA ends; modifica-
tion of the ends to make them compatible and ligatable;
and the final ligation step [68]. This process determines
the two important characteristics of NHEJ: first, neither
LCRs nor MEPS are obligatorily required for NHEJ; and
second, NHEJ leaves an 'information scar' [71] at thePathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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rejoining site as the pre-rejoining editing of the ends
includes cleavage or addition of several nucleotides from
or to the ends [71].
Nobile et al. and Toffolati et al. [72,73] sequenced the
breakpoints of 19 patients with muscular dystrophy due
to non-recurrent deletions in introns 47 and 48 of the
DMD gene. These deletions were not flanked by LCRs and
the junctions showed microhomology (2 to 4 nucle-
otides) in seven cases, short insertions (1 to 5 nucleotides)
in three cases and short duplications of surrounding frag-
ments up to 25 bp in three cases. Other junctions either
contained short sequences of unknown origin or did not
show any microhomology, which might be due to the
editing process in NHEJ. These events thus fit well with
the features of the NHEJ mechanism. Remarkably,16 of
the 38 (42%) breakpoints in these two publications fell
within repetitive elements such as LTR, LINE, Alu, MIR
and MER2 DNA elements; also, sequence motifs known
to be capable of causing DSB or curving DNA, such as
TTTAAA, are present in proximity to many of these junc-
tions [72,73].
DNA replication Figure 3
Genomic rearrangement mechanisms. a. (Adapted from [66]) Non-homologous end-joining (NHEJ) in vertebrates. A 
double-stranded DNA break (DSB) occurs and is repaired via NHEJ mechanism. The two thick lines depict two DNA strands 
with DSB, the thin segments in the middle represent the modifications which the ends have gone through before the final liga-
tion. The enzyme machineries catalyzing each step are briefly summarized. They are described in details in references [65] and 
[70]. Note at step 3 that in order to repair ends, some addition or deletion of bases may be required, leaving behind a 'signa-
ture' of NHEJ. b. (Adapted from [82]) After the original stalling of the replication fork (dark blue and red, solid lines), the lag-
ging strand (red, dotted line) disengages and anneals to a second fork (purple and green, solid lines) via microhomology (1), 
followed by (2) extension of the now 'primed' second fork and DNA synthesis (green, dotted line). After the fork disengages 
(3), the tethered original fork (dark blue and red, solid lines) with its lagging strand (red and green, dotted lines) could invade a 
third fork (gray and black, solid lines). Dotted lines represent newly synthesized DNA. Serial replication fork disengaging and 
lagging strand invasion could occur several times (e.g. FoSTeS x 2, FoSTeS x 3, ... etc.) before (4) resumption of replication on 
the original template.
ȝ ȜPathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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Inoue et al. identified two apparently NHEJ-mediated
deletions of the PLP1 (proteolipid protein) gene in Xq22
in patients with Pelizaeus-Merzbacher disease (PMD;
MIM312080). Breakpoint analysis showed 12 base pair
and 34 base pair sequences of unknown origin at the junc-
tion [74]. Interestingly, the distal breakpoints of both
deletions were located in a 32 kb LCR termed LCR-PMDB
[74]. Shaw and Lupski reported two non-recurrent SMS
deletions apparently caused by NHEJ; the proximal break-
points of both deletions are localized in an LCR (the prox-
imal SMS-REP) [75]. One of them occurred within a
MER5B transposon element in the SMS-REP, while the
other was located in proximity to a MIR3 element and an
L2 LINE sequence. The distal breakpoint of the latter dele-
tion was localized between an LIMC4 LINE element and
an AluSc element [75]. Many breakpoints of 17p translo-
cations and other unusual-sized deletions also occurred
within LCRs [76]. Consistent with the finding of repetitive
and DNA breaking elements at the NHEJ breakpoints by
Toffolatti et al. and Nobile et al., the locations of the PLP1
deletions and SMS deletions as well as the 17p transloca-
tion and deletion breakpoints map within the LCRs and
are close to other repetitive DNA elements. These findings
suggest that although NHEJ is not directly mediated by
nor strictly dependent on certain genomic architectural
elements in the way that NAHR is dependent on LCRs, it
may still be stimulated and regulated by the genomic
architecture [4,76].
Combined with the DSB homologous repair (HR) as a
two-step mechanism, NHEJ was also used to explain
duplications [77,78]. Woodward et al. and Lee et al.
observed non-recurrent duplications in the PLP1 region in
the majority of PMD patients; these duplications are non-
recurrent although some of them do show breakpoint
grouping (not clustering) at one end (Figure 1c) [77,78].
Most of the duplications are tandem in orientation. Padi-
ath et al. observed similar non-recurrent tandem duplica-
tions in the LMNB1 (coding for Lamin B1) region in
subjects with autosomal dominant leukodystrophy [79].
The junctions sometimes show microhomology [77,79],
and sometimes have insertions of one to six nucleotides
[77,78]. Woodward et al. and Lee et al. proposed that in
the first step of the rearrangement, a single DSB occurred
in one strand; one of the broken ends then invaded and
copied from the sister chromatid and caused the duplica-
tion. The ends were then rejoined via NHEJ [77,78].
A DNA replication-based mechanism FoSTeS 
can account for complex genomic 
rearrangements
The study of rearrangement mechanisms obviously bene-
fits from the development of new techniques to observe
the rearrangements and breakpoints with a higher resolu-
tion. In the past, fluorescence in situ hybridization (FISH)
has defined the duplications and deletions with resolu-
tion to about one BAC clone (150 to 200 kb) and acceler-
ated the discovery of NAHR and NHEJ mechanisms.
Recently, the advent of array-based CGH [reviewed in
[80,81]] has provided an unprecedented ability to observe
the often complex details of genomic rearrangements, and
has led to the proposal of the DNA replication-based
FoSTeS model as the third major mechanism for human
genomic rearrangements [82].
Lee et al. used a 44 K Agilent custom array to study the
genomic region surrounding PLP1 in PMD patients [82].
This array, with resolution of almost two interrogating oli-
gonucleotides each kb, enabled the observation of non-
recurrent rearrangements in PMD patients that were more
complicated than simple duplication or deletion. The
apparent duplications initially observed by FISH are often
actually interrupted by triplicated or deleted fragments, or
fragments with normal copy numbers. Subsequent map-
ping of breakpoints revealed further complexity of these
rearrangements by showing that some of the fragments
are inverted or translocated to another region. Micro-
homology of two to five nucleotides was found at each
sequenced breakpoint junction [82]. One of the PMD
cases resulting from FoSTeS-mediated complex rearrange-
ment of the PLP1 locus is shown in Figure 4.
It is difficult to explain this complexity by either the
NAHR or NHEJ recombination mechanisms. Inspired by
the findings in Escherichia coli [83], Lee et al. proposed the
replication Fork Stalling and Template Switching
(FoSTeS) Model (Figure 3b). According to this model,
during DNA replication, the DNA replication fork stalls at
one position, the lagging strand disengages from the orig-
inal template, transfers and then anneals, by virtue of
microhomology at the 3' end, to another replication fork
in physical proximity (not necessarily adjacent in primary
sequence), 'primes', and restarts the DNA synthesis [82].
The invasion and annealing depends on the microhomol-
ogy between the invaded site and the original site. Upon
annealing, the transferred strand primes its own template-
driven extension at the transferred fork. This priming
results in a 'join point' rather than a breakpoint, signified
by a transition from one segment of the genome to
another – the template-driven juxtaposition of genomic
sequences. Switching to another fork located downstream
(forward invasion) would result in a deletion, whereas
switching to a fork located upstream (backward invasion)
results in a duplication. Depending on whether the lag-
ging or leading strand in the new fork was invaded and
copied, and the direction of the fork progression, the erro-
neously incorporated fragment from the new replication
fork would be in direct or inverted orientation to its orig-
inal position. This procedure of disengaging, invading/
annealing and synthesis/extension could occur multiplePathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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times in series (that is, FoSTeS × 2, FoSTeS × 3, and so on)
(Figure 5), likely reflecting the poor processivity of the
involved DNA polymerase, and causing the observed
complex rearrangements.
Array CGH data on several other genomic regions, includ-
ing the SMS/PTLS locus [50,84] (Lupski Lab, manuscript
in preparation) and the MECP2 locus [85-88] have con-
firmed the complex nature of many other non-recurrent
rearrangements, some of which were thought to be simple
One Pelizaeus-Merzbacher disease (PMD)-associated complex PLP1 rearrangement results from multiple FoSTeS events,  FoSTeS × 3 (Adapted from [82]) Figure 4
One Pelizaeus-Merzbacher disease (PMD)-associated complex PLP1 rearrangement results from multiple 
FoSTeS events, FoSTeS × 3 (Adapted from [82]). a. Duplication junctions (vertical dotted lines) for one PMD patient 
are displayed relative to reference sequence, with the duplicated region boxed. Two or three base pairs of microhomology 
were found at the breakpoint junctions (i.e. "joint points") after amplification with outward-facing primers (F and R). b. Illustra-
tion of the order, origins, and relative orientations of junctional (pink and blue) and boundary reference sequences (orange and 
green) for the PMD patient. Arrowheads show direction of DNA relative to the positive strand; filled arrowheads with circled 
numbers below represent a FoSTeS event; open arrowhead marks resumption of replication on the original template. Proximal 
(centromeric) and distal (telomeric) are in relation to PLP1 (red circle).PathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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deletion or tandem duplication before the oligoarray
technique was available. Likewise, the FoSTeS mechanism
can potentially explain some of the complex rearrange-
ments observed at the DMD locus [89]. The FoSTeS model
is currently the only major rearrangement mechanism
that could explain these complex rearrangements. Fur-
thermore, some complex chromosome rearrangements
(CCR) unveiled by recent cytogenetic data can also be
explained by FoSTeS [84]. Intriguingly, some tandem
duplications in the PLP1 and LMNB region [77,79] which
were previously explained by a model combining HR and
NHEJ, especially those with microhomology at the junc-
tion [77,79], can be more parsimoniously explained by
the FoSTeS model including the strand switching template
only once (FoSTeS × 1).
Interestingly, similar to the PLP1 region, the SMS/PTLS
and MECP2 regions were also found to have very complex
Comparison of non-allelic homologous recombination, non-homologous end-joining and Fork Stalling and Template Switching  mechanisms resulting in genomic duplication/deletion Figure 5
Comparison of non-allelic homologous recombination, non-homologous end-joining and Fork Stalling and 
Template Switching mechanisms resulting in genomic duplication/deletion. The two thin lines in all three schemes 
represent the double strands of DNA. Left column: An intrachromatid non-allelic homologous recombination (NAHR) event. 
Rectangles in different shades of blue depict two directly orientated low-copy reapeats (LCRs) sharing high homology (97% to 
98%), which align at non-allelic rather than allelic positions and the subsequent recombination causes deletion or duplication 
(reciprocal events but not with equivalent frequencies) of part of the two LCRs as well as the segment flanked by them. Middle 
column: a non-homologous end-joining (NHEJ) event. Double-strand breaks (DSBs) are created between the two sequences 
represented as a blue and a red rectangle with no homology between each other. The NHEJ system modifies and rejoins the 
two ends, resulting in the deletion of the segment between the two DSBs. Right column: a Fork Stalling and Template Switching 
(FoSTeS) × 2 event causing a complex deletion involving two fragments. No extensive homology is required between the sub-
strate sequences depicted by a blue, a red and a green rectangle. However, the small open triangle heading downwards depicts 
a site bearing microhomology (2 to 5 base pairs) between the blue and the red sequences, and the small filled triangle heading 
downwards depicts another site bearing microhomology between the red and the green sequences. Different from NAHR and 
NHEJ, the FoSTeS event occurs during DNA replication. The replication forks from the two surrounding sequences are shown 
in the same color as the rectangles. The leading nascent strand at the left side (blue or red) fork invades the right side (red or 
green) fork via the demonstrated microhomology, and primes its own further synthesis using the right side fork as template. 
This event happens twice, causing deletion of the two fragments flanked by each pair of microhomology sites. Note the juxta-
position of genomic sequences from multiple distinct regions yielding complex rearrangements.PathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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genomic architecture with multiple LCRs [1,85,86]. These
LCRs, although they do not mediate FoSTeS directly,
might be able to bring replication forks together to facili-
tate the replication fork switching event. Furthermore,
highly enriched Alu  repeats and high GC-content
sequences were observed in proximity to the MECP2 com-
plex recombination region [85]. So, like NAHR and NHEJ,
FoSTeS is probably also influenced by the local genomic
architecture. Unlike NAHR or NHEJ, FoSTeS rearrange-
ment is currently based on the translocation of the end of
a single nascent strand, so the genomic architectures facil-
itating FoSTeS may function via a mechanism that does
not involve DSB intermediates. Nevertheless, a micro-
homology-mediated break-induced replication (MMBIR)
model has also been proposed, in which the rearrange-
ment is initiated by a single-end double-strand DNA
break resulting from a collapsed replication fork (Hast-
ings et al. personal communication). As more and more
sophisticated array techniques are being used in more and
more laboratories, we look forward to the discovery of
more complex rearrangements and using them to further
verify and modify the current FoSTeS model.
Some gross genomic rearrangements and small-
scale gene mutations might share similar 
mechanisms
The most significant difference between FoSTeS and the
other two rearrangement mechanisms (NAHR, NHEJ) is
that it is a replication-based mechanism; the rearrange-
ment is induced by errors in the replication procedure. It
has been thought that small monogenic genetic muta-
tions often reflect errors of DNA replication and/or repair
[4], whereas genomic rearrangements are thought to be
caused by other mechanisms induced by or associated
with structural features (genomic architecture) of the local
genomic region [1]. The FoSTeS mechanism suggests that
large genomic rearrangement involving thousands or even
millions of DNA base pairs can be due to replication
errors as well, perhaps also stimulated by local genome
architecture such as cruciforms (Figure 6).
Chen and colleagues [90-93] studied the breakpoints of
'smaller' DNA rearrangements (between 21 bp and up to
10 kb) including duplications, deletions, insertions, and
inversions collected in the Human Gene Mutation Data-
base (HGMD) [94]. They found that many of them have a
Genomic architecture is crucial for the genomic rearrangements Figure 6
Genomic architecture is crucial for the genomic rearrangements. The low-copy repeats serve as substrates and thus 
are an indispensable requirement of non-allelic homologous recombination. Current data suggest that local genomic architec-
ture, including palindromes or cruciforms, might be a stimulus for the Fork Stalling and Template Switching (FoSTeS) rear-
rangement as well, although these architectural elements are not necessarily directly involved in the FoSTeS rearrangement per 
se. This could account for the observation of breakpoint grouping with non-recurrent rearrangements at some loci.PathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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complex nature (similar to the complex nature of the
'large' rearrangements now being observed using array
CGH), instead of being simple duplications and dele-
tions. They proposed the serial replication slippage (SRS)
model to explain these complex gene mutations. The SRS
model is an extension of the classical replication slippage
model [95]; it assumes that the 3' end of the nascent
strand could dissociate from the original template and
invade other templates on the basis of microhomology.
Depending on whether the strand slippage occurs for-
wards or backwards, the nascent strand will have a dele-
tion or duplication. Making use of reversed repeats, the
nascent strand can also invade in the reverse orientation
and thus incorporate an inverted segment. The slippage
can happen serially, creating the complex rearrangements
Chen et al. observed of small sizes between 21 bp and sev-
eral kb.
The SRS model proposed for small gene mutations shares
some general features with the FoSTeS model proposed
for the larger rearrangements. Both models assume serial
replication slippage, and both stress the importance of the
genomic architectural elements such as palindromic
DNA, stem-loop structures, repeats and so on, which may
facilitate the initial stalling of the replication fork. While
the SRS model assumes that replication slippage occurs on
closely adjacent sites (possibly inside the same replication
fork) and causes DNA rearrangements of small sizes, the
FoSTeS model emphasizes that the template switch can
occur over long distances (120 kb to 550 kb observed to
date) to another replication fork (given the spatial close-
ness of the two forks) and cause DNA rearrangements on
a much larger scale. Furthermore, FoSTeS × 1 could
explain deletion and duplication events previously pro-
posed to occur via NHEJ, in a way similar to the explana-
tion of small deletions and duplication using the SRS
model; the observed microhomology at the join point
reflecting the priming event rather than a recombination/
repair process. It is interesting to realize that although we
have been talking about monogenic (often small) and
genomic (often large) rearrangements in different con-
texts, some of them apparently have similar complexity
and might be caused by very similar mechanisms.
Conclusion
NAHR was the first major DNA rearrangement mecha-
nism identified to cause genomic disorders. NAHR occurs
during both meiosis and mitosis and it requires two LCRs
with sufficient length of high homology to act as recombi-
nation substrates (Figures 2 and 6). Based upon the prin-
ciples or 'rules' elucidated by studies of this mechanism,
new genomic disorders have been successfully predicted
and uncovered. Although this LCR-based prominent
theme of NAHR remains the same, recent research has
shown that some details of NAHR mechanism, such as the
frequency of the recombination and the length require-
ment of homology between the LCRs, can differ between
males and females and between meiosis and mitosis.
NHEJ and FoSTeS were later employed to explain other
genomic rearrangements. Both models are still awaiting
more data for further elucidation and modification.
FoSTeS is a unique mechanism compared with NAHR and
NHEJ, especially in that it is a replication-based rearrange-
ment pathway and does not necessarily rely on the pre-
formation of DSB. Although still very limited, our prelim-
inary data imply that FoSTeS might be a major mecha-
nism for duplication CNV and thus a major driver of the
Ohno 'gene duplication/divergence' evolutionary hypoth-
esis [96]. Indeed, FoSTeS might also have been the driving
force in the origin of the LCRs in the human genome. It is
well known that DNA polymerases have an intrinsic error
rate leading to base substitution, a fact which is central to
genome stability, disease origins and evolution of species.
It is tempting to speculate that there may be an endog-
enous polymerase error rate for FoSTeS as well, analogous
to the base substitution error rate. A related question
would be whether or not disorders that are frequently spo-
radic and occur via FoSTeS are associated with advanced
paternal age, as are point mutations that are due to DNA
replication errors [19]. It has been proposed that carriers
of hereditary non-polyposis colon cancer (HNPCC,
MIM120435) with mutations in genes involved in the
DNA mismatch repair pathway may be more susceptible
to somatic genome rearrangements caused by NAHR
events [97]. One could also hypothesize that some other
individuals could be more prone to genomic rearrange-
ments mediated by FoSTeS because of mutations/func-
tional polymorphisms in the DNA replication machinery.
It has been clearly shown that both NHEJ and FoSTeS can
be indeed stimulated by local genomic architecture, but
no direct association of specific DNA elements with either
model (such as LCRs associated with NAHR) has been
experimentally identified. It is an interesting question to
which degree NHEJ and FoSTeS are structurally deter-
mined or enhanced by specific genome architecture and
whether some day we may be able to predict regions of
human genome instability caused by NHEJ and FoSTeS
events, as we have predicted NAHR events and the related
genomic disorders. Currently limited data suggest that a
palindrome or cruciform may stimulate FoSTeS (Figure
6).
There are still many unsolved, exciting questions regard-
ing the mechanisms of human genomic rearrangements
in general. Evidence is emerging that genomic rearrange-
ments, despite their likely common basic mechanisms,
might be differently regulated between germ line and
somatic cells, between embryogenesis and adulthood,PathoGenetics 2008, 1:4 http://www.pathogenetics.com/content/1/1/4
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and between cancer cells, stem cells, and differentiated
cells [98,99]. It is well known that other genome activities
(such as transcription) can be fundamentally different in
different cellular settings. It is thus tempting to relate the
differences in genomic arrangements within these devel-
opmental contexts and cellular environments to the dif-
ferences of other genome-involving processes, and to ask
the question of whether there is an interaction or some
kind of crosstalk between genomic rearrangement and
other cellular processes. We know that NHEJ rearrange-
ments are physiologically relevant in generating antibody
diversity [66]; are there other 'programmed' rearrange-
ments including inversions [27] which are employed in
the development or regulation of other biological events?
Finally, are there other mechanisms for genomic rear-
rangements in addition to the three discussed in this
review?
For the latter question, some data are starting to emerge
from two genome-wide structural variation studies. Kor-
bel et al. [100] and Kidd et al. [101] used the paired-end-
mapping (PEM) [100] and the fosmid-based end-
sequencing-pair (ESP) [101] methods respectively, to sys-
tematically identify structural variants (SVs) in human
genomes. Korbel et al. identified 1297 SVs including 853
deletions, 322 insertions and 122 inversions, and
sequenced the breakpoints of 188 SV indels and 14 inver-
sions. It is very interesting that almost all of the SVs bear
signatures of either NAHR (surrounded by LCRs or repet-
itive sequences such as SINEs, LINEs), NHEJ or FoSTeS
(microhomology at the junction), or retrotranspositions
(mostly L1 elements). (Retrotransposition causes rear-
rangements in the genome via RNA-mediated mecha-
nisms and is not the subject of this review.) Very few SVs
do not fall into any of the three categories (Korbel, per-
sonal communications). Kidd et al. inferred mechanisms
from breakpoints analysis for 227 SV indels and 34 inver-
sions, and similarly identified evidence for NAHR, NHEJ
or FoSTeS mechanisms. There are differences between the
results of the two papers. The calculated ratio of NAHR-
mediated events in SV indels, for example, is 14% accord-
ing to Korbel et al., but much higher (39%) in Kidd et al.
These differences may be due to the differences in their
methodology or design; that of Kidd et al. is likely more
efficient in detecting larger variations. Nevertheless, it
seems that the three major rearrangement mechanisms –
NAHR, NHEJ and FoSTeS – can explain the majority of the
DNA rearrangements occurring in our genomes.
It is also of interest that the sequence analysis of both
studies indicated that a portion of NAHR events utilize
repetitive elements (SINEs, LINEs, LTRs), rather than
LCRs as homology substrates. This finding is consistent
with our previous data [75] showing that some non-recur-
rent deletions of SMS patients can be mediated by NAHR
between Alu sequences. These Alus are from the evolution-
arily youngest subfamilies AluS and AluY, and share a high
degree of homology with each other. This homology
apparently fulfills the conditions for MEPS and is enough
to enable occasional non-allelic homology mediated
recombination between two Alu sequences. However, the
length of homology between two Alu sequences is much
shorter than that between two usual LCRs, which may
explain the lower frequency of the Alu-mediated recombi-
nation events than the LCR-mediated NAHRs.
Both PEM and ESP are based on the sequencing of small
fragments (~3 kb for PEM and up to 40 kb for ESP) of the
individual genomes and then comparing the distance
between both ends of the fragments with the value of the
reference genome. It should be noted that large duplica-
tions that can not be spanned by these small fragments
might be underrepresented in the SVs identified by PEM
and ESP because of the design of the methodology. Fur-
thermore, these approaches: (i) may not readily detect
complex genomic rearrangements, and (ii) the computa-
tional "filtering" accompanying the match of shotgun and
short sequence reads to the reference genome may result
in lack of identification of breakpoint sequences. On the
other hand, this strategy is very powerful in identifying
DNA sequence read information at the breakpoints of the
deletion and inversion SVs. Future developments of even
more sophisticated and sensitive genome-wide assay tech-
nologies will provide a more extensive overview of the
structural variants in our genome and greatly facilitate the
research on the mechanisms for CNV and other genomic
rearrangements.
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